An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors

Published:2015-04-27 Issue:4 Volume:35 Page:438-447
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Carvalho S,Lindzen M,Lauriola M,Shirazi N,Sinha S,Abdul-Hai A,Levanon K,Korach J,Barshack I,Cohen Y,Onn A,Mills G,Yarden Y

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc201593.pdf

Reference52 articles.

1. Witsch E, Sela M, Yarden Y . Roles for growth factors in cancer progression. Physiology (Bethesda) 2010; 25: 85–101.

2. Burgess AW . EGFR family: structure physiology signalling and therapeutic targets. Growth Factors 2008; 26: 263–274.

3. Hynes NE, MacDonald G . ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 2009; 21: 177–184.

4. Jones JT, Akita RW, Sliwkowski MX . Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett 1999; 447: 227–231.

5. Kochupurakkal BS, Harari D, Di-Segni A, Maik-Rachline G, Lyass L, Gur G et al. Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J Biol Chem 2005; 280: 8503–8512.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amivantamab efficacy in wild-type EGFR NSCLC tumors correlates with levels of ligand expression;npj Precision Oncology;2024-09-06

2. Amphiregulin Downregulates E-cadherin Expression by Activating YAP/Egr-1/Slug Signaling in SKOV3 Human Ovarian Cancer Cells;Reproductive Sciences;2024-08-13

3. Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma;2024-07-02

4. Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment;Frontiers in Pharmacology;2024-05-20

5. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma;Cells;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3